CN Patent

CN117120090A — Hpk1拮抗剂和其用途

Assigned to Limbers Sutton Co · Expires 2023-11-24 · 2y expired

What this patent protects

本发明提供了化合物、其组合物和使用其抑制HPK1并治疗HPK1介导的病症的方法。

USPTO Abstract

本发明提供了化合物、其组合物和使用其抑制HPK1并治疗HPK1介导的病症的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN117120090A
Jurisdiction
CN
Classification
—
Expires
2023-11-24
Drug substance claim
No
Drug product claim
No
Assignee
Limbers Sutton Co
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.